Guangzhou Baiyunshan Pharmaceutical Holdings Company Statistics

Total Valuation

Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of CNY 42.18 billion. The enterprise value is 40.48 billion.

Market Cap	42.18B
Enterprise Value	40.48B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Oct 25, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	876.22M

Valuation Ratios

The trailing PE ratio is 12.32.

PE Ratio	12.32
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 34.68.

EV / Earnings	11.82
EV / Sales	0.51
EV / EBITDA	7.99
EV / EBIT	9.93
EV / FCF	34.68

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.37.

Current Ratio	1.46
Quick Ratio	1.09
Debt / Equity	0.37
Debt / EBITDA	2.88
Debt / FCF	12.00
Interest Coverage	9.08

Financial Efficiency

Return on equity (ROE) is 9.73% and return on invested capital (ROIC) is 4.85%.

Return on Equity (ROE)	9.73%
Return on Assets (ROA)	3.18%
Return on Capital (ROIC)	4.85%
Revenue Per Employee	2.72M
Profits Per Employee	122,055
Employee Count	28,048
Asset Turnover	0.99
Inventory Turnover	6.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.09%
50-Day Moving Average	28.76
200-Day Moving Average	29.35
Relative Strength Index (RSI)	31.72
Average Volume (20 Days)	6,906,786

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of CNY 76.39 billion and earned 3.42 billion in profits. Earnings per share was 2.11.

Revenue	76.39B
Gross Profit	12.93B
Operating Income	3.91B
Pretax Income	4.36B
Net Income	3.42B
EBITDA	4.59B
EBIT	3.91B
Earnings Per Share (EPS)	2.11

Full Income Statement

Balance Sheet

The company has 17.47 billion in cash and 14.01 billion in debt, giving a net cash position of 3.46 billion.

Cash & Cash Equivalents	17.47B
Total Debt	14.01B
Net Cash	3.46B
Net Cash Per Share	n/a
Equity (Book Value)	38.05B
Book Value Per Share	22.28
Working Capital	16.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.45 billion and capital expenditures -1.28 billion, giving a free cash flow of 1.17 billion.

Operating Cash Flow	2.45B
Capital Expenditures	-1.28B
Free Cash Flow	1.17B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 16.92%, with operating and profit margins of 5.12% and 4.48%.

Gross Margin	16.92%
Operating Margin	5.12%
Pretax Margin	5.71%
Profit Margin	4.48%
EBITDA Margin	6.01%
EBIT Margin	5.12%
FCF Margin	1.53%

Dividends & Yields

This stock pays an annual dividend of 1.15, which amounts to a dividend yield of 4.16%.

Dividend Per Share	1.15
Dividend Yield	4.16%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	46.58%
Buyback Yield	-0.01%
Shareholder Yield	4.15%
Earnings Yield	7.68%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guangzhou Baiyunshan Pharmaceutical Holdings Company has an Altman Z-Score of 2.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	n/a